Thrombocytopenic Purpura: Clinical Trials

6 trials for Thrombocytopenic Purpura, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 1 unknown. 3 Phase 3, 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 33Completed 3
Phase 11Completed 1
Phase 21Completed 1

Follow Thrombocytopenic Purpura: new trials by email Literature Review of Thrombocytopenic Purpura trials Research Report on Thrombocytopenic Purpura

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Lymphocyte Counts in Immune Thrombocytopenic Purpura
complete blood picture - Thrombocytopenic Purpura
UnknownAssiut University12017-10-012017-08-09
Safety and Efficacy Study of Romiplostim to Treat Immune Thrombocytopenia (ITP) in Pediatric Patients
Romiplostim, Placebo - Idiopathic Thrombocytopenic Purpura, Thrombocytopenia
Phase 3CompletedAmgen622012-01-012017-02-09
Romiplostim (AMG 531) Versus Medical Standard of Care for Immune (Idiopathic) Thrombocytopenic Purpura
Medical Standard of Care for ITP, Romiplostim - Idiopathic Thrombocytopenic Purpura, Thrombocytopenia
Phase 3CompletedAmgen2342006-12-012022-11-08
Retrospective & Prospective Observational Study of Patients With Immune (Idiopathic) Thrombocytopenic Purpura (ITP)
Retrospective Chart Review, Patient-reported Outcome Questionnaires, Physician Survey - Idiopathic Thrombocytopenic Purpura, Thrombocytopenia
CompletedAmgen3262006-05-012013-11-26
An Open Label Study of Romiplostim in Adult Thrombocytopenic Subjects With ITP
Romiplostim - Idiopathic Thrombocytopenic Purpura, Thrombocytopenia
Phase 3CompletedAmgen4072005-02-012022-11-14
Amgen Megakaryopoiesis Protein 2 (AMG 531) in Thrombocytopenic Subjects With Immune Thrombocytopenic Purpura (ITP)
Romiplostim - Thrombocytopenic Purpura
Phase 1 / Phase 2CompletedAmgen162002-12-022023-06-26

Narrower conditions

Purpura, Thrombocytopenic (6)  ·  Purpura, Thrombocytopenic, Idiopathic (5)  ·  Thrombocytopenia (5)  ·  Hematologic Diseases (2)  ·  Hemostatic Disorders (2)  ·  Jacobs syndrome (2)

Broader conditions

Blood Coagulation Disorders (6)  ·  Blood Platelet Disorders (6)  ·  Cytopenia (6)  ·  Hemic and Lymphatic Diseases (6)  ·  Hemorrhage (6)  ·  Immune System Diseases (6)  ·  Pathologic Processes (6)  ·  Pathological Conditions, Signs and Symptoms (6)  ·  Purpura (6)  ·  Signs and Symptoms (6)  ·  Skin Manifestations (6)  ·  Thrombotic Microangiopathies (6)  ·  Autoimmune Diseases (5)  ·  Hemorrhagic Disorders (5)  ·  Hematologic Diseases (4)

Interventions

romiplostim (4)  ·  Inosine Triphosphate (1)

Sponsors

Amgen (5)  ·  Assiut University (1)

Countries

Australia (1)  ·  Canada (1)  ·  United States (1)

Results publications

PMID 27103127